MARKET

ACOR

ACOR

Acorda Thrpeutcs
NASDAQ
14.99
+0.47
+3.24%
Closed 16:42 09/29 EDT
OPEN
15.03
PREV CLOSE
14.52
HIGH
15.03
LOW
14.05
VOLUME
3.39K
TURNOVER
--
52 WEEK HIGH
24.80
52 WEEK LOW
5.22
MARKET CAP
18.62M
P/E (TTM)
-0.8774
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at ACOR last week (0925-0929)?
Weekly Report · 1h ago
Weekly Report: what happened at ACOR last week (0918-0922)?
Weekly Report · 09/25 09:26
Overview Of Value Stocks In The Healthcare Sector
Benzinga · 09/18 14:43
Weekly Report: what happened at ACOR last week (0911-0915)?
Weekly Report · 09/18 09:25
Weekly Report: what happened at ACOR last week (0904-0908)?
Weekly Report · 09/11 09:25
Weekly Report: what happened at ACOR last week (0828-0901)?
Weekly Report · 09/04 12:18
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga · 08/30 13:06
Weekly Report: what happened at ACOR last week (0821-0825)?
Weekly Report · 08/28 09:26
More
About ACOR
Acorda Therapeutics, Inc. is a biopharmaceutical company. The Company is focused on developing therapies that restore function and enhance the lives of people with neurological disorders. The Company uses its ARCUS pulmonary delivery system, which is a technology platform designed to deliver medication through inhalation that is used in the development of a variety of inhaled medicines. The Company’s commercial products include INBRIJA (levodopa inhalation powder) and AMPYRA (dalfampridine). Inbrija is an inhaled levodopa (L-dopa) for intermittent treatment of OFF episodes, also known as OFF periods in people with Parkinson’s disease treated with carbidopa/levodopa regimen. Inbrija utilizes its ARCUS platform for inhaled therapeutics. AMPYRA (dalfampridine) is an extended-release tablet formulation of dalfampridine as a treatment to enhance walking in patients with multiple sclerosis (MS). Ampyra is marketed as Fampyra outside the United States by Biogen International GmbH.

Webull offers kinds of Acorda Therapeutics Inc stock information, including NASDAQ:ACOR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ACOR stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading ACOR stock methods without spending real money on the virtual paper trading platform.